Microfluidic Platforms for Ex Vivo and In Vivo Gene Therapy
Biosensors · 2025
DOI: 10.3390/bios15080504 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, 2025. Verfasst von Sungjun Kwak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences and Bioengineering, Inha University, Incheon 22212, Republic of Korea. Hauptthemen laut MEDLINE: Genetic Therapy, Gene Transfer Techniques, Microfluidics. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inha University, Inha University Research Grant.
Abstract (Originalsprache)
Recent studies have demonstrated the clinical potential of nucleic acid therapeutics (NATs). However, their efficient and scalable delivery remains a major challenge for both ex vivo and in vivo gene therapy. Microfluidic platforms have emerged as a powerful tool for overcoming these limitations by enabling precise intracellular delivery and consistent therapeutic carrier fabrication. This review examines microfluidic strategies for gene delivery at the cellular level. These strategies include mechanoporation, electroporation, and sonoporation. We also discuss the synthesis of lipid nanoparticles, polymeric particles, and extracellular vesicles for systemic administration. Unlike conventional approaches, which treat ex vivo and in vivo delivery as separate processes, this review focuses on integrated microfluidic systems that unify these functions. For example, genetic materials can be delivered to cells that secrete therapeutic extracellular vesicles (EVs), or engineered cells can be encapsulated within hydrogels for implantation. These strategies exemplify the convergence of gene delivery and carrier engineering. They create a single workflow that bridges cell-level manipulation and tissue-level targeting. By synthesizing recent technological advances, this review establishes integrated microfluidic platforms as being fundamental to the development of next-generation NAT systems that are scalable, programmable, and clinically translatable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biological Sciences and Bioengineering, Inha University, Incheon 22212, Republic of Korea.
- Department of Biological Engineering, Inha University, Incheon 22212, Republic of Korea.
- Biohybrid Systems Research Center (BSRC), Inha University, 100 Inha-ro, Michuhol-gu, Incheon 22212, Republic of Korea.
- Department of Mechanical Engineering, Inha University, Incheon 22212, Republic of Korea.
ORCID-Profile: Tae-Joon Jeon, Sun Min Kim, Hyunil Ryu
Förderung
- Inha University
- Inha University Research Grant
Zitieren
APA
Kwak, S., Lee, H., Yu, D., Jeon, T. J., Kim, S. M., & Ryu, H. (2025). Microfluidic Platforms for Ex Vivo and In Vivo Gene Therapy. Biosensors. https://doi.org/10.3390/bios15080504
Vancouver
Kwak S, Lee H, Yu D, Jeon TJ, Kim SM, Ryu H. Microfluidic Platforms for Ex Vivo and In Vivo Gene Therapy. Biosensors. 2025. doi:10.3390/bios15080504
BibTeX
@article{Kwak2025,
author = {Kwak, Sungjun and Lee, Hyojeong and Yu, Dongjun and Jeon, Tae-Joon and Kim, Sun Min and Ryu, Hyunil},
title = {Microfluidic Platforms for Ex Vivo and In Vivo Gene Therapy},
journal = {Biosensors},
year = {2025},
doi = {10.3390/bios15080504}
}
EUVIMED